InsideArbitrage Event Driven Monitor – October 24, 2022
Quick updates on the event-driven strategies we follow on InsideArbitrage.
Merger Arbitrage
- Myovant Sciences (MYOV) to be acquired by Sumitovant Biopharma for $2.9 billion or $27.00 per share in cash.
- Applied Genetic Technologies Corporation (AGTC) to be acquired by Syncona Limited for $23.5 million. Under the terms of the agreement, shareholders of Applied Genetic Technologies Corporation will receive $0.34 per share in cash at the closing of the transaction plus potential future aggregate cash payments of up to $50.0 million (up to $0.73 per share) pursuant to contingent value rights (CVRs).
- Callodine has completed the acquisition of Manning & Napier (MN).
Only plus or premium subscribers can access this post. Subscribe today.
